Literature DB >> 25113827

[Organ and function preservation in urethral cancer].

S Tritschler1, K Lellig, A Roosen, A Horng, C Stief.   

Abstract

Primary urethral carcinomas are rare tumors that can occur both in men and women. Histological patterns of these tumors are mixed, urothelial tumors occur as well as squamous cell tumors or adenocarcinomas.There are different clinical factors that define clinical prognosis, and the 1- and 5-year cancer-free survival is 75% and 54%. Therapy of locally limited disease is surgical resection, and organ-preserving treatment is possible if negative frozen sections prove complete surgical resection. However, in men a perineal urethrostomy might be necessary, and in women there is a high risk of urinary incontinence if more than 2 cm of the distal urethra is resected.In case of locally advanced tumors or tumors of the proximal urethra, a radical urethrectomy with supravesical urinrary diversion is necessary. In some cases neoadjuvant (radio-)chemotherapy may be an option.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25113827     DOI: 10.1007/s00120-014-3555-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  15 in total

1.  Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists.

Authors:  Farshid Dayyani; Curtis A Pettaway; Ashish M Kamat; Mark F Munsell; Kanishka Sircar; Lance C Pagliaro
Journal:  Urol Oncol       Date:  2012-04-24       Impact factor: 3.498

2.  The treatment of primary urethral carcinoma--the dilemmas of a rare condition: experience with partial urethrectomy and adjuvant chemotherapy.

Authors:  O W Hakenberg; H J Franke; M Froehner; M P Wirth
Journal:  Onkologie       Date:  2001-02

3.  Surgery for urethral cancer.

Authors:  R Jeffrey Karnes; Rodney H Breau; Deborah J Lightner
Journal:  Urol Clin North Am       Date:  2010-08       Impact factor: 2.241

4.  Rare cancers are not so rare: the rare cancer burden in Europe.

Authors:  Gemma Gatta; Jan Maarten van der Zwan; Paolo G Casali; Sabine Siesling; Angelo Paolo Dei Tos; Ian Kunkler; Renée Otter; Lisa Licitra; Sandra Mallone; Andrea Tavilla; Annalisa Trama; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2011-10-25       Impact factor: 9.162

5.  Incidence and survival of rare urogenital cancers in Europe.

Authors:  O Visser; J Adolfsson; S Rossi; J Verne; G Gatta; M Maffezzini; K N Franks
Journal:  Eur J Cancer       Date:  2011-11-24       Impact factor: 9.162

6.  Incidence of primary urethral carcinoma in the United States.

Authors:  Mia A Swartz; Michael P Porter; Daniel W Lin; Noel S Weiss
Journal:  Urology       Date:  2006-12-04       Impact factor: 2.649

7.  Male urethral carcinoma: analysis of treatment outcome.

Authors:  G Dalbagni; Z F Zhang; L Lacombe; H W Herr
Journal:  Urology       Date:  1999-06       Impact factor: 2.649

8.  Combination radiation and chemotherapy for the treatment of squamous cell carcinoma of the male and female urethra.

Authors:  M R Licht; E A Klein; R Bukowski; J E Montie; J P Saxton
Journal:  J Urol       Date:  1995-06       Impact factor: 7.450

Review 9.  Successful treatment for squamous cell carcinoma of the female urethra with combined radio- and chemotherapy.

Authors:  Isao Hara; Satoko Hikosaka; Hiroshi Eto; Hideaki Miyake; Yuji Yamada; Toshinori Soejima; Kazuro Sugimura; Sadao Kamidono
Journal:  Int J Urol       Date:  2004-08       Impact factor: 3.369

10.  Surgical treatment for local control of female urethral carcinoma.

Authors:  David S Dimarco; Connie S Dimarco; Horst Zincke; Maurice J Webb; Sarah E Bass; Jeffrey M Slezak; Deborah J Lightner
Journal:  Urol Oncol       Date:  2004 Sep-Oct       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.